Related Experiment Videos
Determination of anti-Cryptosporidium coproantibodies by time-resolved immunofluorometric assay
1Parasitaire, Faculté de Pharmacie, Université René Descartes, Paris, France.
Insights
Researchers developed a new assay to measure antibodies against Cryptosporidium in stool. In AIDS patients, this revealed an elevated immune response, but it did not prevent disease progression.
Area of Science:
- Immunology
- Infectious Diseases
- Gastroenterology
Background:
- The mucosal immune response is crucial for controlling intestinal infections like cryptosporidiosis.
- Hyperimmune colostrum studies suggest a role for mucosal immunity against Cryptosporidium.
- Understanding the specific immune response in immunocompromised individuals is vital.
Purpose of the Study:
- To develop a sensitive and specific assay for detecting anti-Cryptosporidium coproantibodies.
- To investigate the intestinal immune response to Cryptosporidium infection in patients with Acquired Immune Deficiency Syndrome (AIDS).
Main Methods:
- Development of a sandwich-type time-resolved immunofluorometric assay for fecal immunoglobulin A (IgA), M (IgM), and G (IgG) antibodies.
- Validation of the assay for sensitivity, specificity, and reproducibility using intra- and inter-assay coefficients of variation.
- Analysis of coproantibody titers in 12 AIDS patients with cryptosporidiosis and 18 healthy controls.
Main Results:
- The developed assay demonstrated satisfactory sensitivity, specificity (100%), and reproducibility for IgA, IgM, and IgG.
- AIDS patients with cryptosporidiosis showed significantly elevated anti-Cryptosporidium IgA and IgM coproantibody titers compared to controls.
- No correlation was observed between antibody titers and the severity of infection (oocyst shedding) in AIDS patients.
Conclusions:
- A novel, sensitive, and specific immunofluorometric assay for detecting anti-Cryptosporidium coproantibodies in fecal samples was successfully developed.
- AIDS patients exhibit an elevated mucosal immune response (IgA and IgM) to Cryptosporidium infection.
- The observed immune response in AIDS patients appears to be non-protective, as it does not correlate with reduced oocyst shedding or disease control.
Abstract:
The role of the mucosal immune response against Cryptosporidium has been suggested by studies on the therapeutic effects of hyperimmune colostrum. In order to study the intestinal response to this infection, we have developed a sandwich-type time-resolved immunofluorometric assay for the determination of anti-Cryptosporidium coproantibodies. This assay has the inherent sensitivity of an immunoassay without the problems due to background responses from other biological compounds, and is thus suitable for faecal samples. The intra-assay coefficients of variation (5.1%, 4.6%, and 5.8% for immunoglobulins (Ig) A, M and G respectively), inter-assay coefficients of variation (9.4%; 10.5% and 12.2% for IgA, IgM and IgG, respectively) and specificity (100% for all 3 isotypes) were all satisfactory. Using this assay to study 12 patients with the acquired immune deficiency syndrome (AIDS) who were infected with cryptosporidiosis, we found a marked elevation of anti-Cryptosporidium IgA and IgM coproantibody titres relative to 18 healthy control values, but no correlation with the gravity of the infection in terms of oocyst shedding. These results suggest that a non-protective mucosal immune response develops to Cryptosporidium in AIDS patients.